Role of Smad4 (DPC4) inactivation in human cancer
- PMID: 12821112
- DOI: 10.1016/s0006-291x(03)01066-0
Role of Smad4 (DPC4) inactivation in human cancer
Abstract
The tumor suppressor gene Smad4 (DPC4) at chromosome 18q21.1 belongs to the Smad family, which mediates the TGFbeta signaling pathway suppressing epithelial cell growth. This review summarizes the mutational events of the Smad4 gene in human cancer. The Smad4 gene is genetically responsible for familial juvenile polyposis, an autosomal dominant disease characterized by predisposition to gastrointestinal polyps and cancer. In this syndrome, polyps are formed by inactivation of the Smad4 gene through germline mutation and loss of the unaffected wild-type allele. In pancreatic and colorectal cancer, inactivation of the Smad4 gene through homozygous deletion or intragenic mutation occurs frequently in association with malignant progression. However, mutation of this gene is seen only occasionally in the rest of human cancers. The majority of Smad4 gene mutations in human cancer are missense, nonsense, and frameshift mutations at the mad homology 2 region (MH2), which interfere with the homo-oligomer formation of Smad4 protein and the hetero-oligomer formation between Smad4 and Smad2 proteins, resulting in disruption of TGFbeta signaling. Supporting evidence for the above observation was provided by genetically manipulated mice carrying either a heterozygote of the Smad4 gene or a compound heterozygote of the Smad4 and APC genes, which develop either gastrointestinal polyps/cancer mimicking familial juvenile polyposis or progressed colorectal cancer, respectively.
Similar articles
-
Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.Mutat Res. 1999 Aug;406(2-4):71-7. doi: 10.1016/s1383-5726(99)00003-5. Mutat Res. 1999. PMID: 10479724
-
Gastrointestinal tumorigenesis in Smad4 (Dpc4) mutant mice.Hum Cell. 2000 Sep;13(3):85-95. Hum Cell. 2000. PMID: 11197776 Review.
-
Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.Cell. 1998 Mar 6;92(5):645-56. doi: 10.1016/s0092-8674(00)81132-0. Cell. 1998. PMID: 9506519
-
Mutations in the SMAD4/DPC4 gene in juvenile polyposis.Science. 1998 May 15;280(5366):1086-8. doi: 10.1126/science.280.5366.1086. Science. 1998. PMID: 9582123
-
DPC4/SMAD4 gene alterations in human cancer, and their functional implications.Ann Oncol. 1999;10 Suppl 4:56-9. Ann Oncol. 1999. PMID: 10436786 Review.
Cited by
-
Protein tyrosine phosphatase PTPN2 regulates TGF-β signaling through Smad4 dephosphorylation.Am J Cancer Res. 2022 Dec 15;12(12):5516-5531. eCollection 2022. Am J Cancer Res. 2022. PMID: 36628288 Free PMC article.
-
miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4.PLoS One. 2017 Oct 24;12(10):e0186718. doi: 10.1371/journal.pone.0186718. eCollection 2017. PLoS One. 2017. PMID: 29065177 Free PMC article.
-
Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.BMC Syst Biol. 2017 Oct 3;11(Suppl 5):92. doi: 10.1186/s12918-017-0466-5. BMC Syst Biol. 2017. PMID: 28984200 Free PMC article.
-
Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.Cancer Res. 2020 Sep 1;80(17):3466-3479. doi: 10.1158/0008-5472.CAN-20-0259. Epub 2020 Jul 8. Cancer Res. 2020. PMID: 32641411 Free PMC article.
-
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.J Med Genet. 2006 Feb;43(2):97-110. doi: 10.1136/jmg.2005.030833. Epub 2005 May 6. J Med Genet. 2006. PMID: 15879500 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
